医学
心脏再同步化治疗
内科学
心脏病学
心脏毒性
心肌病
重症监护医学
癌症治疗
心力衰竭
心源性猝死
癌症
植入式心律转复除颤器
化疗
射血分数
作者
Charlotte Lee,Abhishek Maan,Jagmeet P. Singh,Michael G. Fradley
出处
期刊:Heart Rhythm
[Elsevier]
日期:2021-02-25
卷期号:18 (7): 1223-1229
被引量:6
标识
DOI:10.1016/j.hrthm.2021.02.017
摘要
Our knowledge of associated cardiotoxicities from novel therapeutics in oncology continues to expand. These include arrhythmias from cancer-therapy induced cardiomyopathy resulting from both direct and indirect effects on cardiomyocytes and other mechanisms that can adversely impact cardiovascular outcomes and overall mortality. In this review, we focus on both the arrhythmias of various classes of oncologic agents as well as the use of cardiac implantable electronic devices (cardioverter-defibrillators, permanent pacemakers, and cardiac resynchronization therapy) in cardio-oncology patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI